---
title: "Talis Biomedical (TLIS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TLIS.US/norm.md"
symbol: "TLIS.US"
name: "Talis Biomedical"
parent: "https://longbridge.com/en/quote/TLIS.US.md"
datetime: "2026-05-21T16:52:02.631Z"
locales:
  - [en](https://longbridge.com/en/quote/TLIS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TLIS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TLIS.US/norm.md)
---

# Talis Biomedical (TLIS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
| --- | --- | --- | --- | --- | --- |
| EPS | -4.86 | -7.15 | -7.39 | -8.62 | -8.27 |
| ROE | -67.23% | -82.90% | -71.47% | -70.59% | -58.30% |
| Revenue | - | 73000.00 | 195000.00 | 140000.00 | 581000.00 |
| Net income | -8.85M | -13.04M | -13.46M | -15.68M | -15.03M |

## Balance Sheet (USD)

| Indicator | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
| --- | --- | --- | --- | --- | --- |
| A&L | 72.70M | 82.49M | 94.67M | 107.23M | 123.08M |
| Leverage | 1.50 | 1.46 | 1.37 | 1.31 | 1.28 |
| BVPS | 26.68 | 31.11 | 37.93 | 44.83 | 52.87 |
| Turnover | 0.0042 | 0.0092 | 0.0162 | 0.0146 | 0.0165 |

## Cash Flow Statement (USD)

| Indicator | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -11.33M | -6.43M | -11.36M | -11.14M | -14.27M |
| Investing CF | 84000.00 | 30000.00 | 93000.00 | -70000.00 | -485000.00 |
| Financing CF | 0.0000 | 2000.00 | 0.0000 | 0.0000 | 0.0000 |
| Free CF | -9.31M | -4.06M | -6.83M | -8.10M | -12.31M |